Navigation Links
Mini-Strokes May Cause Vision Loss

Hong Kong researchers implicate silent infarcts in glaucoma

TUESDAY, July 7 (HealthDay News) -- A study of people who suffer the mini-strokes called silent cerebral infarcts could help explain the medical mystery of normal-tension glaucoma, Hong Kong ophthalmologists report.

Glaucoma is the progressive loss of vision caused by deterioration of the optic nerves, which carry signals from the eyes to the brain. It is customarily attributed to abnormally high pressure of the fluid in the eye. But glaucoma can occur in some people who have normal intraocular pressure, a phenomenon that puzzles eye doctors.

The Hong Kong study of 286 people with normal-tension glaucoma found a high incidence of silent cerebral infarcts among those whose loss of vision progressed more rapidly. The finding is in the July issue of Ophthalmology.

"We feel that our study does cast light on the pathogenesis of normal-tension glaucoma," said the study's lead author, Dr. Dexter Y.L. Leung, deputy coordinator of the glaucoma service at Hong Kong Eye Hospital. "We postulate that vascular [blood vessel] risk factors may be interacting with intraocular pressure in causing glaucoma optic neuropathy."

The study found that 29.6 percent of people with silent cerebral infarcts -- symptomless blockages of small brain arteries -- experienced steady deterioration of their vision, whereas such infarcts occurred in only 15.3 percent of those whose glaucoma-caused vision loss did not progress.

All study participants were Chinese, Leung noted. "We feel that a similar silent cerebral infarct-glaucoma relationship is likely to be applicable to other ethnic groups than the Chinese, but more studies are needed to confirm that," he said.

Doctors treating people with normal-tension glaucoma should consider obtaining brain images to determine whether silent infarcts have occurred, Leung said. There has been a debate about whether doing neuroimaging to detect abnormal growths within the brain is worthwhile, he said.

The next step in the Hong Kong research program will be to determine whether the severity of the silent infarcts correlates with the degree of vision loss in glaucoma, Leung said. Such a relationship would confirm the role of silent infarcts in normal-tension glaucoma, he said.

Dr. Andrew Iwach, executive director of the Glaucoma Center of San Francisco and a spokesman for the American Academy of Ophthalmology, said that while the Hong Kong study adds evidence that there might be a vascular effect in normal-tension glaucoma, "at the moment, the only parameter that has been clearly shown to affect patients is lowering eye pressure."

That applies even to people with normal-tension glaucoma, Iwach said. A study done several years ago by the Glaucoma Research Foundation found that lowering eye pressure reduced visual field loss in such cases, he said.

But sudden changes in vision were seen in some study participants, Iwach said, "and one characteristic of a vascular process is that you can have such sudden changes." Though eye pressure remains the dominant factor in glaucoma, "we are continuing to look for other contributing factors, and high on our list has been the vascular component," he said.

Because glaucoma-caused vision loss can be insidious, the American Academy of Ophthalmology recommends that a comprehensive eye examination, with careful checking of the optic nerve, be done no later than age 40, Iwach said.

More information

The U.S. National Eye Institute has more on glaucoma.

SOURCES: Dexter Y.L. Leung, M.D., deputy coordinator, glaucoma service, Hong Kong Eye Hospital; Andrew Iwach, M.D., director, Glaucoma Center of San Francisco; July 2009, Ophthalmology

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study investigates Gore-tex-type device to stop strokes and mini-strokes
2. Statins May Cause Muscle Damage in Some Patients
3. CU-Boulder study shows brains immune system may cause chronic seizures
4. Australian researchers identify genes that cause melanoma
5. Researchers find possible environmental causes for Alzheimers, diabetes
6. Cystic Fibrosis Treatment May Cause Hearing Loss
7. Extreme Heat Causes Major Health Problems for Older Adults
8. Polycystic ovarian syndrome: New light on its causes and its effect on brothers
9. First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks
10. Canadian Bio Med Attacks Worlds Leading Cause of Blindness
11. Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination
Post Your Comments:
Related Image:
Mini-Strokes May Cause Vision Loss
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: